Myers Ce
About
In The Last Decade
Myers Ce
14 papers receiving 460 citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 171
- Oncology 119
- Cardiology and Cardiovascular Medicine 112
- Surgery 102
- Pulmonary and Respiratory Medicine 67
Countries citing papers authored by Myers Ce
This map shows the geographic impact of Myers Ce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myers Ce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myers Ce more than expected).
Fields of papers citing papers by Myers Ce
This network shows the impact of papers produced by Myers Ce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myers Ce. The network helps show where Myers Ce may publish in the future.
Co-authorship network of co-authors of Myers Ce
This figure shows the co-authorship network connecting the top 25 collaborators of Myers Ce. A scholar is included among the top collaborators of Myers Ce based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myers Ce. Myers Ce is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Suramin: prototype of a new generation of antitumor compounds. | 86 |
| 2 | Poikilocytosis in dogs with chronic doxorubicin toxicosis. | 6 |
| 3 | The use of intraperitoneal chemotherapy. | 3 |
| 4 | Phase II trial of 5-FU administered Ip to patients with refractory ovarian cancer. | 16 |
| 5 | Technical considerations in the use of intraperitoneal chemotherapy administered by Tenckhoff catheter. | 55 |
| 6 | Measurement of formulary inclusion costs. | 5 |
| 7 | Chemotherapy for murine ovarian cancer: a rationale for ip therapy with adriamycin. | 28 |
| 8 | The effect of doxorubicin on hepatic and cardiac glutathione. | 66 |
| 9 | Phase II study of high-dose methotrexate in patients with advanced malignant melanoma. | 2 |
| 10 | Clinical pharmacology of anticancer drugs. | 73 |
| 11 | Adriamycin: amelioration of toxicity by alpha-tocopherol. | 89 |
| 12 | Clinical experience with silicotuberculosis. | 2 |
| 13 | Human ultrastructure. IV. Collecting duct of healthy individuals. | 82 |
| 14 | RUPTURE OF THE NORMAL SPLEEN DUE TO VOMITING. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.